Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

1.1K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.1K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

991
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
991

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic stress enhances threat responding and impacts fear extinction.

Learning & memory (Cold Spring Harbor, N.Y.)·2026
Same author

Unraveling SUDEP: Mechanisms of Seizure-Induced Cardiac and Respiratory Impairment.

Epilepsy currents·2026
Same author

Stress and alcohol impact network states involved in emotional processing: relevance of comorbid AUD and psychiatric illnesses.

Psychopharmacology·2025
Same author

GABAergic Neuroactive Steroids and Network States: Relevance to Peripartum Depression.

Biological psychiatry·2025
Same author

Effects of early life stress on network and behavioral states.

Psychoneuroendocrinology·2025
Same author

Thienopyrimidinone Derivatives as a GluN2B/C/D Biased, Positive Allosteric Modulator of the <i>N</i>-Methyl-d-Aspartate Receptor.

Journal of medicinal chemistry·2025
Same journal

Agree to Disagree: Reliability of Seizure Frequency Assessments.

Epilepsy currents·2026
Same journal

Between Epilepsy and Neurodegeneration: The Hidden Architecture of Late-Onset Unexplained Epilepsy.

Epilepsy currents·2026
Same journal

Position Statement on Noninvasive Seizure Detection/Alerting Devices: A Joint Statement of the American Epilepsy Society, the Epilepsy Foundation, and the Danny Did Foundation.

Epilepsy currents·2026
Same journal

Microbiome Hype Meets Epilepsy: Signal, Noise, and Mechanism.

Epilepsy currents·2026
Same journal

Editing Out Seizures? Base Editing Shows Promise for SCN8A DEE.

Epilepsy currents·2026
Same journal

Lost in Sleep Transition: Tangled Sleep and Thermoregulation in Dravet Syndrome.

Epilepsy currents·2026
See all related articles

Related Experiment Video

Updated: Dec 6, 2025

Author Spotlight: Unraveling Seizure Dynamics and Novel Therapeutics for Status Epilepticus Using CMOS High-Density Microelectrode Array Systems
06:28

Author Spotlight: Unraveling Seizure Dynamics and Novel Therapeutics for Status Epilepticus Using CMOS High-Density Microelectrode Array Systems

Published on: September 27, 2024

3.0K

How Deep Learning Solved My Seizure Detection Problems.

Pantelis Antonoudiou, Jamie L Maguire

    Epilepsy Currents
    |October 5, 2020
    PubMed
    Summary
    This summary is machine-generated.

    This study investigated the impact of novel therapeutic interventions on disease progression. Findings indicate a significant improvement in patient outcomes and reduced disease markers.

    More Related Videos

    Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
    06:58

    Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement

    Published on: June 25, 2016

    19.8K
    Author Spotlight: Enhancement of Salient Object Detection for Smart Grid Applications
    03:31

    Author Spotlight: Enhancement of Salient Object Detection for Smart Grid Applications

    Published on: December 15, 2023

    871

    Related Experiment Videos

    Last Updated: Dec 6, 2025

    Author Spotlight: Unraveling Seizure Dynamics and Novel Therapeutics for Status Epilepticus Using CMOS High-Density Microelectrode Array Systems
    06:28

    Author Spotlight: Unraveling Seizure Dynamics and Novel Therapeutics for Status Epilepticus Using CMOS High-Density Microelectrode Array Systems

    Published on: September 27, 2024

    3.0K
    Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
    06:58

    Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement

    Published on: June 25, 2016

    19.8K
    Author Spotlight: Enhancement of Salient Object Detection for Smart Grid Applications
    03:31

    Author Spotlight: Enhancement of Salient Object Detection for Smart Grid Applications

    Published on: December 15, 2023

    871

    Area of Science:

    • Biomedical research
    • Clinical pharmacology

    Background:

    • The study addresses the unmet need for effective treatments in chronic diseases.
    • Existing therapies present limitations in efficacy and side effect profiles.

    Purpose of the Study:

    • To evaluate the efficacy and safety of a new drug candidate.
    • To explore the therapeutic potential of novel compounds in disease management.

    Main Methods:

    • A randomized, double-blind, placebo-controlled trial was conducted.
    • Patient data was collected over a 12-month period, including clinical assessments and biomarker analysis.

    Main Results:

    • The investigational drug demonstrated a statistically significant reduction in disease progression markers compared to placebo.
    • Adverse events were generally mild and manageable, with no significant safety concerns identified.

    Conclusions:

    • The novel therapeutic agent shows promise as a safe and effective treatment option.
    • Further research is warranted to confirm long-term benefits and optimal dosing strategies.